Loading...

Increasing Price Controls Will Limit Diagnostics Prospects

Published
01 Sep 25
AnalystLowTarget's Fair Value
US$265.00
11.5% overvalued intrinsic discount
04 Sep
US$295.43
Loading
1Y
-10.4%
7D
-0.8%

Author's Valuation

US$265.0

11.5% overvalued intrinsic discount

AnalystLowTarget Fair Value